John Hart to Anti-Bacterial Agents
This is a "connection" page, showing publications John Hart has written about Anti-Bacterial Agents.
Connection Strength
0.653
-
The safety and efficacy of a single dose of oral azithromycin given in labour to prevent skin and soft tissue infections in young infants in Fiji: a randomised controlled trial. BMC Med. 2025 Apr 28; 23(1):246.
Score: 0.152
-
Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units. PLoS Negl Trop Dis. 2019 10; 13(10):e0007749.
Score: 0.104
-
Mass Oral Azithromycin for Childhood Mortality: Timing of Death After Distribution in the MORDOR Trial. Clin Infect Dis. 2019 05 30; 68(12):2114-2116.
Score: 0.101
-
Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa. N Engl J Med. 2018 Apr 26; 378(17):1583-1592.
Score: 0.093
-
Mass administration of azithromycin and Streptococcus pneumoniae carriage: cross-sectional surveys in the Gambia. Bull World Health Organ. 2014 Jul 01; 92(7):490-8.
Score: 0.071
-
Doxycycline-induced gastric and esophageal mucosal injuries with vascular degeneration. Am J Surg Pathol. 2013 Jul; 37(7):1115-6.
Score: 0.067
-
Gastric mucosal necrosis with vascular degeneration induced by doxycycline. Am J Surg Pathol. 2013 Feb; 37(2):259-63.
Score: 0.065